Eli Lilly Files 2024 10-K, Details Financials
Ticker: LLY · Form: 10-K · Filed: Feb 19, 2025 · CIK: 59478
| Field | Detail |
|---|---|
| Company | Eli Lilly & Co (LLY) |
| Form Type | 10-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, debt
TL;DR
LLY dropped its 2024 10-K. All looks good, debt due in '25, '26, '30.
AI Summary
Eli Lilly and Company (LLY) filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, a major player in pharmaceutical preparations, is incorporated in Indiana and headquartered in Indianapolis. The filing covers various financial aspects, including notes due in 2025, 2026, and 2030, and details its business operations and financial performance for the year.
Why It Matters
This 10-K filing provides a comprehensive overview of Eli Lilly's financial health and operational status for 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual financial filing for a large, established company, providing routine disclosures.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Date the fiscal year concluded)
- 20250219 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- ELI LILLY & Co (company) — Filer
- 0000059478 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- Indianapolis (company) — Headquarters City
- IN (company) — Headquarters State
- 3172762000 (company) — Business Phone Number
- 20241231 (date) — Fiscal Year End
- 20250219 (date) — Filing Date
- LLY:A718NotesDueJune12025Member (dollar_amount) — Debt Instrument
- LLY:A1.625NotesDueJune22026Member (dollar_amount) — Debt Instrument
FAQ
What is Eli Lilly and Company's primary industry classification?
Eli Lilly and Company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
When did Eli Lilly and Company's fiscal year end for this report?
The conformed period of report for this 10-K filing is December 31, 2024.
What is the filing date of this 10-K report?
This 10-K report was filed as of February 19, 2025.
Where is Eli Lilly and Company headquartered?
Eli Lilly and Company is headquartered in Indianapolis, IN.
What are some of the debt instruments mentioned in the filing details?
The filing details mention debt instruments such as LLY:A718NotesDueJune12025Member, LLY:A1.625NotesDueJune22026Member, and LLY:A2.125NotesDueJune32030Membe.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 19, 2025 regarding ELI LILLY & Co (LLY).